| Rapid generation of neutralizing antibody responses in COVID-19 patients MS Suthar, MG Zimmerman, RC Kauffman, G Mantus, SL Linderman, ... Cell Reports Medicine 1 (3), 2020 | 558 | 2020 |
| AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies M Chesi, DF Robbiani, M Sebag, WJ Chng, M Affer, R Tiedemann, ... Cancer cell 13 (2), 167-180, 2008 | 454 | 2008 |
| Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma M Affer, M Chesi, WD Chen, JJ Keats, YN Demchenko, K Tamizhmani, ... Leukemia 28 (8), 1725-1735, 2014 | 287 | 2014 |
| Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t (4; 14) myeloma S Trudel, S Ely, Y Farooqi, M Affer, DF Robbiani, M Chesi, PL Bergsagel Blood 103 (9), 3521-3528, 2004 | 214 | 2004 |
| Identification and characterization of an Xq26–q27 duplication in a family with spina bifida and panhypopituitarism suggests the involvement of two distinct genes FA Hol, MT Schepens, SEC van Beersum, E Redolfi, M Affer, P Vezzoni, ... Genomics 69 (2), 174-181, 2000 | 74 | 2000 |
| Further phenotypic characterization of the primitive lineage− CD34+ CD38− CD90+ CD45RA− hematopoietic stem cell/progenitor cell sub-population isolated from cord blood … D Wisniewski, M Affer, J Willshire, B Clarkson Blood cancer journal 1 (9), e36-e36, 2011 | 67 | 2011 |
| Single-cell analysis suggests that ongoing affinity maturation drives the emergence of pemphigus vulgaris autoimmune disease A Cho, AL Caldara, NA Ran, Z Menne, RC Kauffman, M Affer, A Llovet, ... Cell reports 28 (4), 909-922. e6, 2019 | 40 | 2019 |
| Genetic dissection of dome formation in a mammary cell line: identification of two genes with opposing action I Zucchi, C Montagna, L Susani, R Montesano, M Affer, S Zanotti, ... Proceedings of the National Academy of Sciences 96 (24), 13766-13770, 1999 | 38 | 1999 |
| Gene expression differences between enriched normal and chronic myelogenous leukemia quiescent stem/progenitor cells and correlations with biological abnormalities M Affer, S Dao, C Liu, AB Olshen, Q Mo, A Viale, CL Lambek, TG Marr, ... Journal of oncology 2011 (1), 798592, 2011 | 36 | 2011 |
| Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures B Diamond, B Ziccheddu, K Maclachlan, J Taylor, E Boyle, JA Ossa, ... Blood, The Journal of the American Society of Hematology 141 (19), 2359-2371, 2023 | 26 | 2023 |
| Targeted therapies in cancer: to be or not to be, selective S Montoya, D Soong, N Nguyen, M Affer, SP Munamarty, J Taylor Biomedicines 9 (11), 1591, 2021 | 25 | 2021 |
| Transcription map of Xq27: candidates for several X-linked diseases I Zucchi, J Jones, M Affer, C Montagna, E Redolfi, L Susani, P Vezzoni, ... Genomics 57 (2), 209-218, 1999 | 25 | 1999 |
| Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127 S Montoya, J Bourcier, M Noviski, H Lu, MC Thompson, A Chirino, J Jahn, ... Science 383 (6682), eadi5798, 2024 | 23 | 2024 |
| Rapid generation of neutralizing antibody responses in COVID-19 patients. Cell Rep Med 1: 100040 MS Suthar, MG Zimmerman, RC Kauffman, G Mantus, SL Linderman, ... | 18 | 2020 |
| Kinase dead BTK mutations confer resistance to covalent and noncovalent BTK inhibitors but are susceptible to clinical stage BTK degraders S Montoya, J Bourcier, MC Thompson, M Noviski, M Tan, E Wang, X Mi, ... Blood 140 (Supplement 1), 1811-1813, 2022 | 16 | 2022 |
| Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t (11; 14) N Nguyen, S Chaudhry, TM Totiger, R Diaz, E Roberts, S Montoya, ... NPJ Precision Oncology 6 (1), 73, 2022 | 16 | 2022 |
| Rapid generation of neutralizing antibody responses in COVID-19 patients. Cell Rep Med. 2020; 1 (3): 100040 MS Suthar, MG Zimmerman, RC Kauffman, G Mantus, SL Linderman, ... Epub 2020/08/25. doi: 10.1016/j. xcrm. 2020.100040. PubMed PMID: 32835303, 2020 | 16 | 2020 |
| Identification of CXorfl, a Novel Intronless Gene in Xq27.3, Expressed in Human Hippocampus E Redolfi, C Montagna, S Mumm, L Susani, R Reinbold, F HOL, ... DNA and cell biology 17 (12), 1009-1016, 1998 | 13 | 1998 |
| X-linked retinitis pigmentosa: current status DK Breuer, M Affer, S Andreasson, DG Birch, GA Fishman, ... New insights into retinal degenerative diseases, 11-22, 2001 | 9 | 2001 |
| Mapping of the MYCL2 processed gene to Xq22‐23 and identification of an additional L MYC‐related sequence in Xq27. 2 E Redolfi, A Pizzuti, A Di Bacco, L Susani, T Labella, M Affer, C Montagna, ... FEBS letters 446 (2-3), 273-277, 1999 | 9 | 1999 |
